Research Agreement Will Use Machine Learning to ID Genetic Markers for Pancreatic Cancer” data-reactid=”12″>Research Agreement Will Use Machine Learning to ID Genetic Markers for Pancreatic CancerNEW YORK, March 3, 2020 /PRNewswire/ — Spherix Incorporated (Nasdaq: SPEX) today announced it has executed a Scientific Research Agreement with The University of Texas Southwestern Medical Center with the goal of using machine learning to find genetic markers in people that indicate an increased risk of developing pancreatic cancer.” data-reactid=”13″>NEW YORK, March 3, 2020 /PRNewswire/ — Spherix Incorporated (Nasdaq: SPEX) today announced it has executed a Scientific Research Agreement with The University of Texas Southwestern Medical Center with the goal of using machine learning to find genetic markers in people that indicate an increased risk of developing pancreatic cancer.CisionMoreView original content to download multimedia:http://www.prnewswire.com/news-releases/spherix-executes-machine-learning-scientific-research-agreement-301015388.htmlSOURCE Spherix Incorporated
Source: https://finance.yahoo.com/news/spherix-executes-machine-learning-scientific-142500367.html
